Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Baxter

Showing results (31-40 of 112) with videos related to

Pageof 12
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2013
Lack of association of Guillain-Barré syndrome with vaccinationsRoger Baxter, Nandini Bakshi, Bruce Fireman, et al.
Vaccine|September 18, 2017
Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009-2010Abigail Eaton, Ned Lewis, Bruce Fireman, et al.
Vaccine|March 5, 2019
Long term risk of developing type 1 diabetes after HPV vaccination in males and femalesNicola P Klein, Kristin Goddard, Edwin Lewis, et al.
Vaccine|July 12, 2016
Risk of underlying chronic medical conditions for invasive pneumococcal disease in adultsRoger Baxter, Arnold Yee, Laurie Aukes, et al.
Vaccine|July 11, 2006
Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adultsSteven Black, Henry Shinefield, Roger Baxter, et al.
The Pediatric Infectious Disease Journal|June 15, 2004
Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser PermanenteSteven Black, Henry Shinefield, Roger Baxter, et al.
The Pediatric Infectious Disease Journal|August 4, 2015
Five-year Antibody Persistence and Booster Response to a Single Dose of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Adolescents and Young Adults: An Open, Randomized TrialRoger Baxter, Yaela Baine, Devayani Kolhe, et al.
Vaccine|May 17, 2017
Waning protection following 5 doses of a 3-component diphtheria, tetanus, and acellular pertussis vaccineNicola P Klein, Joan Bartlett, Bruce Fireman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 30, 2009
Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescentsLisa A Jackson, Roger Baxter, Keith Reisinger, et al.
The Pediatric Infectious Disease Journal|June 10, 2014
Antibody persistence after primary and booster doses of a quadrivalent meningococcal conjugate vaccine in adolescentsRoger Baxter, Keith Reisinger, Stanley L Block, et al.
Pageof 12

Showing results (31-40 of 112) with videos related to

Sort By:
Pageof 12
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2013
Lack of association of Guillain-Barré syndrome with vaccinationsRoger Baxter, Nandini Bakshi, Bruce Fireman, et al.
Vaccine|September 18, 2017
Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009-2010Abigail Eaton, Ned Lewis, Bruce Fireman, et al.
Vaccine|March 5, 2019
Long term risk of developing type 1 diabetes after HPV vaccination in males and femalesNicola P Klein, Kristin Goddard, Edwin Lewis, et al.
Vaccine|July 12, 2016
Risk of underlying chronic medical conditions for invasive pneumococcal disease in adultsRoger Baxter, Arnold Yee, Laurie Aukes, et al.
Vaccine|July 11, 2006
Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adultsSteven Black, Henry Shinefield, Roger Baxter, et al.
The Pediatric Infectious Disease Journal|June 15, 2004
Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser PermanenteSteven Black, Henry Shinefield, Roger Baxter, et al.
The Pediatric Infectious Disease Journal|August 4, 2015
Five-year Antibody Persistence and Booster Response to a Single Dose of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Adolescents and Young Adults: An Open, Randomized TrialRoger Baxter, Yaela Baine, Devayani Kolhe, et al.
Vaccine|May 17, 2017
Waning protection following 5 doses of a 3-component diphtheria, tetanus, and acellular pertussis vaccineNicola P Klein, Joan Bartlett, Bruce Fireman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 30, 2009
Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescentsLisa A Jackson, Roger Baxter, Keith Reisinger, et al.
The Pediatric Infectious Disease Journal|June 10, 2014
Antibody persistence after primary and booster doses of a quadrivalent meningococcal conjugate vaccine in adolescentsRoger Baxter, Keith Reisinger, Stanley L Block, et al.
Pageof 12